Liposomal cisplatin in combination with gemcitabine for untreated locally advanced or metastatic pancreatic cancer
Status In progress
Process STA pre-2018
Referral date 01 November 2014

Scoped as part of Batch 37


Provisional Schedule

Closing date for invited submissions / evidence submission: TBC
1st appraisal committee meeting: TBC

Project Team

Associate Director: TBC
Communications manager: TBC
Project manager:


Technical Advisor: TBC
Technical Lead: TBC


Key events during the development of the guidance:

Date Update
22 January 2015 Following on from advice received from the company, the dates for this appraisal will be confirmed once regulatory approval timelines are established.

For further information on how we develop guidance, please see our page about NICE technology appraisal guidance